Ultralife (NASDAQ:ULBI) Third Quarter 2022 ResultsKey Financial Results
- Revenue: US$33.2m (up 53% from 3Q 2021).
- Net loss: US$239.0k (loss narrowed by 59% from 3Q 2021).
- US$0.015 loss per share (improved from US$0.036 loss in 3Q 2021).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Ultralife EPS Misses Expectations
Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates.
Looking ahead, revenue is forecast to grow 8.4% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Electrical industry in the US.
The company's shares are down 15% from a week ago.
Risk AnalysisWhat about risks? Every company has them, and we've spotted 1 warning sign for Ultralife you should know about.
Valuation is complex, but we're helping make it simple.
Find out whether Ultralife is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.View the Free Analysis
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.